• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Reciprocal Interactions Between the Gut Microbiome and Mammary Tissue Mast Cells Promote Metastatic Dissemination of HR+ Breast Tumors.肠道微生物组与乳腺组织肥大细胞的相互作用促进 HR+ 乳腺癌的转移扩散。
Cancer Immunol Res. 2022 Nov 2;10(11):1309-1325. doi: 10.1158/2326-6066.CIR-21-1120.
2
Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor-Positive Breast Cancer.共生菌预先失调是激素受体阳性乳腺癌组织炎症和肿瘤细胞扩散的宿主内在调节因子。
Cancer Res. 2019 Jul 15;79(14):3662-3675. doi: 10.1158/0008-5472.CAN-18-3464. Epub 2019 May 7.
3
Mast Cells in Mammary Carcinogenesis: Host or Tumor Supporters?乳腺肿瘤发生中的肥大细胞:宿主细胞还是肿瘤支持者?
Anticancer Res. 2017 Mar;37(3):1013-1021. doi: 10.21873/anticanres.11411.
4
Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice.在c-Kit突变的Sash小鼠中,乳腺肿瘤的生长和转移受到抑制。
Cancer Med. 2016 Jun;5(6):1292-7. doi: 10.1002/cam4.696. Epub 2016 Mar 19.
5
Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis.肠维生素 D 受体可预防肠外乳腺癌发生。
Gut Microbes. 2023 Jan-Dec;15(1):2202593. doi: 10.1080/19490976.2023.2202593.
6
Genistein Reduces the Risk of Local Mammary Cancer Recurrence and Ameliorates Alterations in the Gut Microbiota in the Offspring of Obese Dams.金雀异黄素降低肥胖母鼠后代乳腺局部癌症复发风险并改善其肠道微生物群的改变。
Nutrients. 2021 Jan 11;13(1):201. doi: 10.3390/nu13010201.
7
The Relationship of Tumor Microbiome and Oral Bacteria and Intestinal Dysbiosis in Canine Mammary Tumor.犬乳腺肿瘤中肿瘤微生物组与口腔细菌和肠道菌群失调的关系。
Int J Mol Sci. 2022 Sep 18;23(18):10928. doi: 10.3390/ijms231810928.
8
Altered gut microbiome drives heightened pain sensitivity in a murine model of metastatic triple-negative breast cancer.肠道微生物群改变驱动转移性三阴性乳腺癌小鼠模型的疼痛敏感性增强。
Am J Cancer Res. 2024 Jan 15;14(1):274-299. doi: 10.62347/LUJF9626. eCollection 2024.
9
Translocation of synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis.协同易位与髓系来源的抑制细胞协同作用,并有助于乳腺癌发生。
Oncoimmunology. 2022 Mar 26;11(1):2057399. doi: 10.1080/2162402X.2022.2057399. eCollection 2022.
10
Sialic acid exacerbates gut dysbiosis-associated mastitis through the microbiota-gut-mammary axis by fueling gut microbiota disruption.唾液酸通过为肠道菌群破坏提供燃料,通过菌群-肠道-乳腺轴加剧与肠道菌群失调相关的乳腺炎。
Microbiome. 2023 Apr 17;11(1):78. doi: 10.1186/s40168-023-01528-8.

引用本文的文献

1
Mast cell heparanase promotes breast cancer stem-like features via MUC1/estrogen receptor axis.肥大细胞乙酰肝素酶通过 MUC1/雌激素受体轴促进乳腺癌干细胞样特征。
Cell Death Dis. 2024 Sep 30;15(9):709. doi: 10.1038/s41419-024-07092-9.
2
Breast Cancer: Extracellular Matrix and Microbiome Interactions.乳腺癌:细胞外基质与微生物组的相互作用。
Int J Mol Sci. 2024 Jun 30;25(13):7226. doi: 10.3390/ijms25137226.
3
The regulatory role and mechanism of mast cells in tumor microenvironment.肥大细胞在肿瘤微环境中的调节作用及机制。
Am J Cancer Res. 2024 Jan 15;14(1):1-15. doi: 10.62347/EZST5505. eCollection 2024.
4
Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor.肠道微生物群与乳腺癌的关联:饮食作为潜在的调节因素。
Nutrients. 2023 Oct 31;15(21):4628. doi: 10.3390/nu15214628.
5
Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy.微环境中的“亦敌亦友”:利用肥大细胞进行癌症免疫治疗
Pharmaceutics. 2023 Jun 9;15(6):1692. doi: 10.3390/pharmaceutics15061692.

本文引用的文献

1
Controversial role of mast cells in breast cancer tumor progression and angiogenesis.肥大细胞在乳腺癌肿瘤进展和血管生成中的争议性作用。
Clin Breast Cancer. 2021 Dec;21(6):486-491. doi: 10.1016/j.clbc.2021.08.010. Epub 2021 Aug 31.
2
Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth.抗生素引起的肠道微生物群紊乱会导致乳腺肿瘤生长加速。
iScience. 2021 Aug 20;24(9):103012. doi: 10.1016/j.isci.2021.103012. eCollection 2021 Sep 24.
3
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment.肠道微生物群影响早期乳腺癌治疗的临床结局和副作用。
Cell Death Differ. 2021 Sep;28(9):2778-2796. doi: 10.1038/s41418-021-00784-1. Epub 2021 May 7.
4
Understanding mast cell heterogeneity at single cell resolution.单细胞分辨率下理解肥大细胞异质性。
Trends Immunol. 2021 Jun;42(6):523-535. doi: 10.1016/j.it.2021.04.004. Epub 2021 May 4.
5
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.肿瘤浸润肥大细胞与抗 PD-1 治疗耐药相关。
Nat Commun. 2021 Jan 12;12(1):346. doi: 10.1038/s41467-020-20600-7.
6
Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination.成纤维细胞对乳腺发育、乳腺癌微环境重塑及癌细胞播散的影响
Cancers (Basel). 2020 Jun 26;12(6):1697. doi: 10.3390/cancers12061697.
7
Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype.浸润性肥大细胞介导的刺激乳腺癌细胞雌激素受体活性促进腔细胞表型。
Cancer Res. 2020 Jun 1;80(11):2311-2324. doi: 10.1158/0008-5472.CAN-19-3596. Epub 2020 Mar 16.
8
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy.肿瘤微环境中的细胞外基质及其对癌症治疗的影响。
Front Mol Biosci. 2020 Jan 31;6:160. doi: 10.3389/fmolb.2019.00160. eCollection 2019.
9
Impact of the microbiome on cancer progression and response to anti-cancer therapies.微生物组对癌症进展和抗癌治疗反应的影响。
Adv Cancer Res. 2019;143:255-294. doi: 10.1016/bs.acr.2019.03.005. Epub 2019 Apr 17.
10
Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor-Positive Breast Cancer.共生菌预先失调是激素受体阳性乳腺癌组织炎症和肿瘤细胞扩散的宿主内在调节因子。
Cancer Res. 2019 Jul 15;79(14):3662-3675. doi: 10.1158/0008-5472.CAN-18-3464. Epub 2019 May 7.

肠道微生物组与乳腺组织肥大细胞的相互作用促进 HR+ 乳腺癌的转移扩散。

Reciprocal Interactions Between the Gut Microbiome and Mammary Tissue Mast Cells Promote Metastatic Dissemination of HR+ Breast Tumors.

机构信息

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia.

Gut Microbes and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom.

出版信息

Cancer Immunol Res. 2022 Nov 2;10(11):1309-1325. doi: 10.1158/2326-6066.CIR-21-1120.

DOI:10.1158/2326-6066.CIR-21-1120
PMID:36040846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9633553/
Abstract

Establishing commensal dysbiosis, defined as an inflammatory gut microbiome with low biodiversity, before breast tumor initiation, enhances early dissemination of hormone receptor-positive (HR+) mammary tumor cells. Here, we sought to determine whether cellular changes occurring in normal mammary tissues, before tumor initiation and in response to dysbiosis, enhanced dissemination of HR+ tumors. Commensal dysbiosis increased both the frequency and profibrogenicity of mast cells in normal, non-tumor-bearing mammary tissues, a phenotypic change that persisted after tumor implantation. Pharmacological and adoptive transfer approaches demonstrated that profibrogenic mammary tissue mast cells from dysbiotic animals were sufficient to enhance dissemination of HR+ tumor cells. Using archival HR+ patient samples, we determined that enhanced collagen levels in tumor-adjacent mammary tissue positively correlated with mast cell abundance and HR+ breast cancer recurrence. Together, these data demonstrate that mast cells programmed by commensal dysbiosis activate mammary tissue fibroblasts and orchestrate early dissemination of HR+ breast tumors.

摘要

在乳腺癌起始前建立共生失调,定义为具有低生物多样性的炎症性肠道微生物组,可增强激素受体阳性(HR+)乳腺肿瘤细胞的早期扩散。在这里,我们试图确定在肿瘤起始前和对失调的反应中发生在正常乳腺组织中的细胞变化是否增强了 HR+肿瘤的扩散。共生失调增加了正常非肿瘤乳腺组织中肥大细胞的频率和促纤维化性,这种表型变化在肿瘤植入后仍然存在。药理和过继转移方法表明,来自失调动物的促纤维化性乳腺组织肥大细胞足以增强 HR+肿瘤细胞的扩散。使用存档的 HR+患者样本,我们确定肿瘤附近乳腺组织中增强的胶原蛋白水平与肥大细胞丰度和 HR+乳腺癌复发呈正相关。总之,这些数据表明,共生失调编程的肥大细胞激活乳腺组织成纤维细胞,并协调 HR+乳腺癌的早期扩散。